» Articles » PMID: 12374535

Viral Disease Transmitted by Laser-generated Plume (aerosol)

Overview
Journal Arch Dermatol
Specialty Dermatology
Date 2002 Oct 11
PMID 12374535
Citations 57
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To evaluate the possibility of disease transmission through liberated plume from virally infected tissue that is exposed to the carbon dioxide laser.

Design: Bovine papillomavirus-induced cutaneous fibropapillomas were exposed to the carbon dioxide laser. Laser settings were within the range of clinically used settings. The laser plume (aerosol) was suctioned and collected and then reinoculated onto the skin of calves.

Setting: University laboratory research center.

Main Outcome Measures: Laser plume viral content and postinoculation tumor growth were analyzed and documented.

Results: Collected laser plume contained papillomavirus DNA in all tested laser settings. The viral DNA was most likely encapsulated. Tumors developed at laser plume-inoculated sites for all laser parameter settings. Histological and biochemical analyses revealed that these tumors were infected with the same virus type as present in the laser plume.

Conclusions: Laser plume has been shown, for the first time to our knowledge, to actually transmit disease. Strict care must be maintained by the laser practitioner to minimize potential health risks, especially when treating viral-induced lesions or patients with viral disease.

Citing Articles

Virus and viral components transmitted through surgical smoke; a silent danger in operating room: a systematic review.

Mahdood B, Merajikhah A, Mirzaiee M, Bastami M, Banoueizadeh S BMC Surg. 2024; 24(1):227.

PMID: 39123160 PMC: 11312259. DOI: 10.1186/s12893-024-02514-z.


Aerosol generation during surgical tracheostomy in a patient with COVID-19.

McGain F, Humphries R, Mora J, Timms P, Hill F, French C Crit Care Resusc. 2023; 22(4):391-393.

PMID: 38046872 PMC: 10692572. DOI: 10.51893/2020.4.rl2r.


Viral load of SARS-CoV-2 in surgical smoke in minimally invasive and open surgery: a single-center prospective clinical trial.

Cizmic A, Eichel V, Weidner N, Wise P, Muller F, Rompen I Sci Rep. 2023; 13(1):20299.

PMID: 37985848 PMC: 10662446. DOI: 10.1038/s41598-023-47058-z.


Vaccinating Providers for HPV Due to Transmission Risk in Ablative Dermatology Procedures.

Bourgeois J, Ross L J Clin Aesthet Dermatol. 2023; 16(9):26-27.

PMID: 37720197 PMC: 10503934.


Human Papillomavirus Epidemiology and Prevention: Is There Still a Gender Gap?.

Milano G, Guarducci G, Nante N, Montomoli E, Manini I Vaccines (Basel). 2023; 11(6).

PMID: 37376449 PMC: 10303003. DOI: 10.3390/vaccines11061060.